Dr. Rutledge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 Camino de Salud NE
Albuquerque, NM 87102Phone+1 505-925-0461Fax+1 505-925-0454
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2001 - 2004
- University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 1997 - 2001
- Texas A&M; Health Science Center College of MedicineClass of 1997
Certifications & Licensure
- NM State Medical License 2007 - 2026
- OK State Medical License 1998 - 2012
- NC State Medical License 2004 - 2009
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsFlexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.Doris M. Benbrook, Scott A. Kamelle, Suresh Guruswamy, Stan Lightfoot, Teresa L. Rutledge
Investigational New Drugs. 2005-10-01 - 28 citationsSerous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.Kathleen N. Moore, Katherine M. Moxley, Amanda N. Fader, Allison E. Axtell, Rodney P. Rocconi
Gynecologic Oncology. 2007-12-01 - 13 citationsExtraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.Kathleen N. Moore, Michael A. Gold, D. Scott McMeekin, Joan L. Walker, Teresa Rutledge
Gynecologic Oncology. 2008-03-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: